利用血清PSA及其衍生數據預測再次攝護腺切片結果之研究

Optimal Predictors on Repeat Prostate Biopsy : A Retrospective Analysis

陳卷書(Chuan-Shu Chen)

指導教授 ： 周明智

中山醫學大學/醫學院/醫學研究所/碩士(2010年)

https://doi.org/10.6834/CSMU.2010.00025

摘要

研究背景：
臨床醫師運用抽血測量血清特異性攝護腺抗原 (Prostate-Specific antigen, PSA)及攝護腺肛門指診 (Digital Rectal Examination, DRE)篩檢攝護腺癌，對於上述兩種檢測若有任何一種出現異常，則該病患將接受經直腸超音波導引攝護腺切片。若切片結果為陰性的病患，而血清PSA持續異常，未來仍可能接受再次切片，但是目前除了血清PSA外，有其他PSA衍生數據來增加切片的陽性預測率。本研究即是收集過去接受再次切片的病人，利用統計方法回溯性探討何種PSA衍生數據是較佳的攝護腺癌預測因子。
材料與方法 :
本研究回溯性收集台中榮民總醫院從1999年至2008年間所有接受二次經直腸超音波導引攝護腺切片的病患，其中排除DRE異常及血清PSA大於10 ng/ml的病患，有212位病患被納入本研究，我們收集這212位病患的血清總PSA(total PSA, tPSA)自由型PSA(free PSA, fPSA)佔總PSA(tPSA)之比值(f/t PSA)，PSA密度(PSA density, PSAD)及PSA上升速度(PSA velocity, PSAV)，並利用反應者操作特徵曲線(Receiver Operating Characteristic Curve, ROC curve)，在比較上述各種PSA衍生數據的優劣，最後再次利用統計方法找出各種PSA衍生數據的最佳閾值。
結果 :
本研究納入之212位病患中，有26人接受再次切片後，診斷為攝護腺癌，而其餘的186人診斷為良性攝護腺增生。各種PSA衍生數據在反應者操作特徵曲線下的面積分別是tPSA為72.7%，f/t PSA為57.9%，PSAD為74.4%及PSAV為64.8%，以上結果反應PSAD優於f/t PSA，成為一個較佳的攝護腺預測因子。此外，當PSAD的閾值定在0.18 ng/ml/cc 的時候，預測攝護腺癌的特異度高達69%，且其敏感度為77%是可以接受的範圍。
結論 :
於再次攝護腺切片的病患中，PSAD的確優於f/t PSA，成為一個較佳的攝護腺癌預測因子，並且PSAD提供較高特異度以減少不必要的再次切片。

關鍵字

攝護腺 ； 切片 ； 攝護腺特異性抗原 ； 攝護腺特異性抗原密度 ； 自由型攝護腺特異性抗原

並列摘要

Purpose: The aim of our study was to identify the optimal predictor of prostate cancer among several prostate-specific antigen (PSA) derivatives in repeat prostate biopsy.
Methods: We retrospectively assessed the repeat prostate biopsy specimens, obtained between 1999 and 2008, of 212 patients with total PSA (tPSA) of 4-10 ng/ml and normal digital rectal examination (DRE). Using receiver operating characteristic (ROC) analysis, we assessed the predictive power of tPSA, percent free PSA (f/t PSA), PSA density (PSAD), and PSA velocity (PSAV) for detection of prostate cancer.
Results: Repeat prostate biopsy specimens were positive for prostate cancer in the case of 26 patients and negative in the case of 186 patients. The areas under the ROC curve for tPSA, f/tPSA, PSAD, and PSAV were 72.7%, 57.9%, 74.4%, and 64.8%, respectively. The ROC curve analysis revealed that PSAD was a better predictor of prostate cancer than f/t PSA. Moreover, when PSAD at an optimal cutoff of 0.18 ng/ml/cc was considered as the predictor, the detection of prostate cancer was found to have a high sensitivity and specificity ( 77% and 69%, respectively).
Conclusions: In repeat prostate biopsy, PSAD is superior to f/t PSA as a predictor of prostate cancer and by assessing this predictor, unnecessary repeat biopsy of patients with tPSA of 4-10 ng/ml can be avoided.

並列關鍵字

prostate ； biopsy ； prostate-specific antigen ； PSA density ； free PSA

參考文獻

1 Matsuda T, Saika K: Comparison of time trends in prostate cancer incidence (1973-2002) in asia, from cancer incidence in five continents, vols iv-ix. Jpn J Clin Oncol 2009;39:468-469.

2 Matsuda T, Saika K: Comparison of time trends in prostate cancer incidence (1973-1997) in east asia, europe and USA, from cancer incidence in five continents vols iv-viii. Jpn J Clin Oncol 2007;37:556-557.

3 Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS, Redwine E: Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med 1987;317:909-916.

4 Luboldt HJ, Bex A, Swoboda A, Husing J, Rubben H: Early detection of prostate cancer in germany: A study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff. Eur Urol 2001;39:131-137.

5 Djavan B, Zlotta A, Remzi M, Ghawidel K, Basharkhah A, Schulman CC, Marberger M: Optimal predictors of prostate cancer on repeat prostate biopsy: A prospective study of 1,051 men. J Urol 2000;163:1144-1148; discussion 1148-1149.